Clinical Trial Update: Study to Evaluate the Efficacy and Safety of MEDI9929 (AMG 157) in Adult Subjects With Inadequately Controlled, Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating MEDI9929 (AMG 157) for adult asthma has completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• MEDI9929 (AMG 157)

Snippet

Sponsor: MedImmune LLC | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2018-12-04